Copertina

Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alexander R. Zheutlin, Joshua A. Jacobs, Joshua D. Niforatos, Alexander Chaitoff
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Chloride dipstick to rapidly estimate urine sodium during diuresis in acute heart failure
di: Vacha Shah, et al.
Pubblicazione: (2025)

Prevalence of potentially inappropriately prescribed medications among older adults receiving peritoneal dialysis
di: Armando Silva Almodovar, et al.
Pubblicazione: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
di: Trisha Matsuura, et al.
Pubblicazione: (2025)

Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018
di: Mahek Garg, et al.
Pubblicazione: (2024)

Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data
di: Ashna Talwar, et al.
Pubblicazione: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
di: Mohammed Aldhaeefi, et al.
Pubblicazione: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
di: Nicholas C. Tonial, et al.
Pubblicazione: (2025)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
di: Tyler Chanas, et al.
Pubblicazione: (2024)

Comment on “Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data”
di: Shih‐Jie Wang, et al.
Pubblicazione: (2025)

Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study
di: Flory T. Muanda, et al.
Pubblicazione: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
di: Erika L. Hellenbart, et al.
Pubblicazione: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
di: Elmar R. Alizadeh, et al.
Pubblicazione: (2024)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
di: Elizabeth M. Sherman, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Assessment of the association between mixed‐oil lipid injectable emulsion use and 30‐day mortality or infection persistence from fungal catheter‐related bloodstream infections in pediatric patients following receipt of parenteral nutrition: A retrospective cohort study
di: Gustavo R. Alvira‐Arill, et al.
Pubblicazione: (2025)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
di: David B. Cluck, et al.
Pubblicazione: (2024)

Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink”
Pubblicazione: (2024)

Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial
di: Nadine K. El‐Nagdy, et al.
Pubblicazione: (2025)

Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study
di: Keisuke Mine, et al.
Pubblicazione: (2025)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
di: Andrew J. Webb, et al.
Pubblicazione: (2025)

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
di: Javeria Khalid, et al.
Pubblicazione: (2026)

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study
di: Arden R. Barry, et al.
Pubblicazione: (2025)

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin
di: Oluwadolapo D. Lawal, et al.
Pubblicazione: (2025)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
di: Iftekhar Ahmed, et al.
Pubblicazione: (2026)

Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study
di: Maria‐Stephanie A. Hughes, et al.
Pubblicazione: (2024)

Insulin requirements after switching from GLP ‐1 receptor agonist to dual GIP / GLP ‐1 receptor agonist in patients with type 2 diabetes mellitus
di: Alexa M. Lahey, et al.
Pubblicazione: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
di: Amira R. Rashdan, et al.
Pubblicazione: (2026)

Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review
di: Brian W. Gilbert, et al.
Pubblicazione: (2025)

Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Pubblicazione: (2024)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to Comment on “Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson’s Disease”
di: Katherine Longardner, et al.
Pubblicazione: (2026)

Incidence of Acute Kidney Injury With the Use of Nafcillin Versus Oxacillin
di: Alejandro D. Perez, et al.
Pubblicazione: (2026)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
di: Erin F. Barreto, et al.
Pubblicazione: (2026)

Exploring variations in recommended first‐choice therapy for complicated urinary tract infections in males: Insights from outpatient settings across age, race, and ethnicity
di: Kathryn Sine, et al.
Pubblicazione: (2024)

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
di: Milre M. Matherne, et al.
Pubblicazione: (2026)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)